Dr Kin Yee Shiu
MBBS, BA HONS (CANTAB), PHD, FRCP
Consultant Nephrologist And Acute Physician
Dr Kin Yee Shiu has been a Consultant Nephrologist and Acute Physician at the Royal Free since 2014. She is Clinical Lead for Chronic Kidney Disease and Renal Outpatients, and honorary senior lecturer (Department of Renal Medicine, UCL).
She graduated with a First Class degree from Cambridge, before completing her medical training at University College London in 1997.
As a general nephrologist, Dr Shiu has a wide breadth of experience in looking after patients with all aspects of kidney disease, including chronic kidney disease, renal diagnostics, acute kidney injury, dialysis and transplantation. Dr Shiu participates regularly in the renal on-call rota, including acute transplantation, and the acute medical rota as an acute medical physician at the Royal Free. She is therefore well-placed to manage patients with nephrological and/or medical conditions, including those with acute or complex needs.
Her research background is in renal transplantation: her PhD was in Transplant Immunology (King’s College London) and she continues to be active in clinical research in the field of transplantation, with expertise in managing renal patients both pre- and post-transplant.
Other areas of interest include championing quality improvement and staff education, working locally and regionally to improve the quality, safety and effectiveness of patient care.
Royal Free Hospital
Country of qualification
- Fellow of the Royal College of Physicians
- Member of the British Transplant Society and Member of the UK Renal Association
- All aspects of Nephrology and Transplantation
- All aspects of Acute Medical care
- Renal biopsy (native and transplant)
- General Nephrology (including Renal Diagnostics, Chronic Kidney Disease, Hypertension, Diabetic Nephropathy)
- Renal Transplantation
Chronic Rejection in Renal Transplant Patients: Principal Investigator at the Royal Free for a large multi-centre NIHR-funded trial determining the utility of biomarkers such as antibodies against the transplant as well as determining the effectiveness of treatment protocols aimed at helping kidney transplants last longer.